CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
Erin M. Bange(Memorial Sloan Kettering Cancer Center), John P. Reilly(University of Pennsylvania), Lova Sun(University of Pennsylvania), Jennifer E. Wu(Parker Institute for Cancer Immunotherapy), Christopher M. McAllister(University of Pennsylvania), C.A.G. Ittner(University of Pennsylvania), Nicholas Han(Translational Therapeutics (United States)), Krista R. Budzik(University of Pennsylvania), Michael Galantino(University of Pennsylvania), Sigrid Gouma(University of Pennsylvania), Adam J. Widman(Memorial Sloan Kettering Cancer Center), Ariel R. Weisman(University of Pennsylvania), Susan DeWolf(Memorial Sloan Kettering Cancer Center), Justin Kim(Translational Therapeutics (United States)), R.S. Agyekum(Translational Therapeutics (United States)), Alfred L. Garfall(University of Pennsylvania), Divij Mathew(Parker Institute for Cancer Immunotherapy), Olutosin Owoyemi(University of Pennsylvania), Emily M. Kugler(University of Pennsylvania), Olutwatosin Oniyide(Presbyterian Hospital), Cécile Alanio(Inserm), Justine V. Cohen(Massachusetts General Hospital), Ivan Maillard(University of Michigan), Tiffanie K. Jones(Translational Therapeutics (United States)), Derek A. Oldridge(California University of Pennsylvania), Madeline A. Hwee(Memorial Sloan Kettering Cancer Center), Karan Naik(University of Pennsylvania), Laura A. Vella(Children's Hospital of Philadelphia), Kara N. Maxwell(Philadelphia VA Medical Center), Sharon Adamski(United States Military Academy), Allison R. Greenplate(California University of Pennsylvania), H.M. Giannini(Lung Institute), Randall A. Oyer(Lancaster General Hospital), Josephine R. Giles(Parker Institute for Cancer Immunotherapy), Susan Tollett(University of Pennsylvania), Carla Wright(University of Pennsylvania), Sawsan R. Boutemine(Memorial Sloan Kettering Cancer Center), Cathy Zheng(University of Pennsylvania), Amy E. Baxter(Translational Therapeutics (United States)), Samuel Kerr(Lancaster General Hospital), Florence Porterfield(University of Pennsylvania), Tara Perloff(Pennsylvania Hospital), Anita Kumar(Memorial Sloan Kettering Cancer Center), Ryan Massa(University of Pennsylvania), James Robinson(University of Pennsylvania), Paul Wileyto(University of Pennsylvania), Madison E. Weirick(University of Pennsylvania), Thomas Dunn(Translational Therapeutics (United States)), N. Esther Babady(Memorial Sloan Kettering Cancer Center)
Cited by 519
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Comprehensive mapping of immune perturbations associated with severe COVID-19
|Science Immunology|2020|801